{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:08:40Z","timestamp":1789456120209,"version":"build-2803163510"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Mycoplasma<\/jats:italic>\n                      pneumoniae pneumonia (MPP) is one of the most common causes of community-acquired pneumonia in children, affecting approximately 10%\u201340% of pediatric pneumonia cases worldwide. Despite advances in diagnostic and therapeutic approaches, the pathogenesis of severe MPP remains incompletely understood, and patients demonstrate highly heterogeneous responses to treatment. Recent evidence suggests that ferroptosis, an iron-dependent form of regulated cell death, may play a critical role in the pathophysiology of MPP. This study aimed to elucidate the molecular mechanisms underlying the interaction between MPP and ferroptosis using bioinformatics approaches, and to identify novel ferroptosis-related biomarkers and therapeutic targets.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We analyzed comprehensive transcriptomic data from two independent publicly deposited pediatric whole-blood cohorts: GSE103119 (discovery cohort: 30 MPP cases and 20 healthy controls; Illumina HumanHT-12 v4.0) and E-MTAB-14588 (validation cohort: 9 MPP cases and 19 healthy controls; RNA-seq). Through systematic comparative analysis and FerrDb annotation, we identified ferroptosis-associated differentially expressed genes and calculated ferroptosis score. Machine learning (L2 logistic regression with nested cross-validation) was applied to develop a ferroptosis gene panel for patient stratification. Functional enrichment analysis, protein-protein interaction networks, and cross-cohort meta-analysis were performed to characterize ferroptosis transcriptomic changes during MPP. Five key genes (ATG7, SLC2A3, PGD, SAT1, OXSR1) were validated in\n                      <jats:italic>Mycoplasma<\/jats:italic>\n                      pneumoniae-infected THP-1 cell line model by qRT-PCR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Bioinformatics analysis identified 259 FerrDb-annotated ferroptosis-related genes in the discovery cohort, with ATG7 showing the strongest upregulated ferroptosis signal. The ferroptosis score in the MPP group showed an increasing trend compared with the control group, replicated in E-MTAB-14588. Cross-cohort meta-analysis of 85 shared ferroptosis genes demonstrated strong effect-direction concordance (Spearman \u03c1 = 0.734,\n                      <jats:italic>P<\/jats:italic>\n                      = 1.36 \u00d7 10\n                      <jats:sup>\u221215<\/jats:sup>\n                      ). Gene Ontology and pathway enrichment analyses demonstrated significant activation of iron metabolism, lipid peroxidation, oxidative stress response, and inflammatory pathways. A five-gene ferroptosis panel (ATG7, SLC2A3, PGD, SAT1, OXSR1) achieved AUC = 0.890 (95% CI 0.800\u20130.980) in discovery cross-validation and AUC = 0.860 (95% CI 0.693\u20131.000) in external validation.\n                      <jats:italic>In vitro<\/jats:italic>\n                      qRT-PCR showed that mRNA expression levels of ATG7, SLC2A3, PGD, SAT1 and OXSR1 were significantly upregulated in\n                      <jats:italic>Mycoplasma<\/jats:italic>\n                      pneumoniae-infected THP-1 compared to control group (all\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study provides comprehensive molecular characterization suggesting ferroptosis involvement in pediatric MPP through integrative transcriptomic profiling and machine learning, complemented by\n                      <jats:italic>in vitro<\/jats:italic>\n                      qRT-PCR experimental validation. The identification of consistent ferroptosis transcriptomic signatures across independent cohorts, a high-performance diagnostic gene panel, and\n                      <jats:italic>in vitro<\/jats:italic>\n                      mRNA-level evidence for ferroptosis-associated gene dysregulation advances our understanding of MPP pathogenesis. ATG7, SLC2A3, PGD, SAT1 and OXSR1 represent potential candidate diagnostic biomarkers and therapeutic targets for personalized treatment strategies, with protein-level, functional,\n                      <jats:italic>in vivo<\/jats:italic>\n                      , and clinical validation required before clinical translation. These findings pave the way for developing ferroptosis-targeted interventions to improve patient outcomes in severe pediatric MPP.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcell.2026.1912712","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:25:08Z","timestamp":1789453508000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative machine learning and transcriptomic analysis reveal a ferroptosis gene signature for pediatric Mycoplasma pneumoniae pneumonia"],"prefix":"10.3389","volume":"14","author":[{"given":"Fangfang","family":"Cao","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Children\u2019s Hospital of Shanxi Women Health Center of Shanxi","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Affiliated Haimen Hospital of Xinglin College, Nantong University","place":["Nantong, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghong","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Qingdao Central Hospital, University of Health and Rehabilitation Sciences Qingdao Central Hospital","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Affiliated Children\u2019s Hospital of Jiangnan University Wuxi Children\u2019s Hospital","place":["Wuxi, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/j.1574-6976.2008.00129.x","article-title":"Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections","volume":"32","author":"Atkinson","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.omtn.2021.05.009","article-title":"Genomic analysis uncovers prognostic and immunogenic characteristics of ferroptosis for clear cell renal cell carcinoma","volume":"25","author":"Bai","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B3","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening Horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"760488","DOI":"10.3389\/fimmu.2021.760488","article-title":"Exhausted and apoptotic BALF T cells in proinflammatory airway milieu at acute phase of severe Mycoplasma pneumoniae pneumonia in children","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Friedmann Angeli","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3389\/fimmu.2018.01403","article-title":"Transcriptome analysis of bronchoalveolar lavage fluid from children with Mycoplasma pneumoniae pneumonia reveals natural killer and T cell-proliferation responses","volume":"9","author":"Gao","year":"2018","journal-title":"Front. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12931-024-02687-4","article-title":"Integrative study of pulmonary microbiome, transcriptome and clinical outcomes in Mycoplasma pneumoniae pneumonia","volume":"25","author":"Huang","year":"2024","journal-title":"Respir. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/nejmoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.freeradbiomed.2018.05.074","article-title":"The tumor suppressor protein p53 and the ferroptosis network","volume":"133","author":"Kang","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1128\/AAC.00048-13","article-title":"Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"57","author":"Kawai","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ppul.20374","article-title":"Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children","volume":"41","author":"Lee","year":"2006","journal-title":"Pediatr. Pulmonol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.1038\/s41586-023-06269-0","article-title":"DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition","volume":"619","author":"Mishima","year":"2023","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/jac\/dks457","article-title":"Macrolide-resistant mycoplasma pneumoniae: its role in respiratory infection","volume":"68","author":"Principi","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","article-title":"Role of GPX4 in ferroptosis and its pharmacological implication","volume":"133","author":"Seibt","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jinf.2008.06.012","article-title":"Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children","volume":"57","author":"Tamura","year":"2008","journal-title":"J. Infect."},{"key":"B24","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CMR.00114-16","article-title":"Mycoplasma pneumoniae from the respiratory tract and beyond","volume":"30","author":"Waites","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fcimb.2018.00382","article-title":"Molecular distance to health transcriptional score and disease severity in children hospitalized with community-acquired pneumonia","volume":"8","author":"Wallihan","year":"2018","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1111\/jcmm.14511","article-title":"Molecular mechanisms of ferroptosis and its role in cancer therapy","volume":"23","author":"Xu","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1128\/AAC.02060-12","article-title":"Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012","volume":"57","author":"Zhao","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0141702","DOI":"10.1371\/journal.pone.0141702","article-title":"Culture-independent detection and genotyping of Mycoplasma pneumoniae in clinical specimens from Beijing, China","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1189647","DOI":"10.3389\/fimmu.2023.1189647","article-title":"Immune response plays a role in Mycoplasma pneumoniae pneumonia","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1912712\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:25:09Z","timestamp":1789453509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1912712\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":31,"alternative-id":["10.3389\/fcell.2026.1912712"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1912712","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1912712"}}